Glioblastoma (GBM) is one of the most aggressive cancers of the brain. Despite extensive
research over the last several decades, the survival rates for GBM have not improved and …

The biology and physics underlying glioblastoma is not yet completely understood, resulting
in the limited efficacy of current clinical therapy. Recent studies have indicated the …

Nanotechnology-based RNA interference (RNAi) has shown great promise in overcoming
the limitations of traditional clinical treatments for glioblastoma (GBM). However, because of …

Globally, the number of cancer cases is rising, with no difference between rich and
undeveloped countries. Although affluent nations have made great improvements in the …

As an ideal in vitro model, brain‐on‐chip (BoC) is an important tool to comprehensively
elucidate brain characteristics. However, the in vitro model for the definition scope of BoC …

Fifteen years after the establishment of the Stupp protocol as the standard of care to treat
glioblastomas, no major clinical advances have been achieved and increasing patient's …

Glioblastoma is the most frequently diagnosed type of primary brain tumour in adults. These
aggressive tumours are characterised by inherent treatment resistance and disease …

In the past few decades, brain diseases have taken a heavy toll on human health and social
systems. Magnetic resonance imaging (MRI), photoacoustic imaging (PA), computed …

Three-dimensional printing technologies allow for the fabrication of complex parts with
accurate geometry and less production time. When applied to biomedical applications, two …

Bioprinting technologies are powerful new bioengineering tools that can spatially reproduce
multiple microenvironmental cues in a highly controlled, tunable, and precise manner. In this …